
Abundance of immune checkpoint molecules and their ligands in Oropharyngeal Squamous cell carcinoma (OPSCC) depends on HPV status and can be modulated by demethylation.
Author(s) -
Adrian Fehn,
Jasmin Ezić,
C Brunner,
MarieNicole Theodoraki,
Johannes Döscher,
Patrick J. Schuler,
Jens Greve,
Ralf Marienfeld,
K. Koretz,
TK Hoffmann,
Simon Laban
Publication year - 2020
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0040-1711022
Subject(s) - immune system , immune checkpoint , decitabine , tumor microenvironment , cancer research , cancer , immunogenicity , biology , demethylation , immunotherapy , immunology , dna methylation , gene expression , genetics , gene